VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹584 Cr | ₹542 Cr | ₹495 Cr | ₹538 Cr | ₹494 Cr |
What is the latest Total Expenditure of VENUS REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹584 Cr |
| Mar2024 | ₹542 Cr |
| Mar2023 | ₹495 Cr |
| Mar2022 | ₹538 Cr |
| Mar2021 | ₹494 Cr |
How is Total Expenditure of VENUS REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹584 Cr | 7.84 | |
| Mar2024 | ₹542 Cr | 9.36 | |
| Mar2023 | ₹495 Cr | -7.91 | |
| Mar2022 | ₹538 Cr | 8.84 | |
| Mar2021 | ₹494 Cr | - | |
Compare Total Expenditure of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,086.2 Cr | 1.7% | 15.4% | 137% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 1.7% |
15.4% |
137% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses